Beruflich Dokumente
Kultur Dokumente
Qualification is a vital element for assuring and managing quality during the devel-
opment of an investment project, and an essential prerequisite to validation.
Very precise definitions for the terms qualification and validation can be found (Fig.
6.03) in the recently published PIC/S guide for good practices for the preparation of
medicinal products in healthcare establishments [6.01], e.g. hospital pharmacies:
- Qualification is the risk based, systematic and documented action of proving that
facilities, rooms or equipment work correctly, are suitable for the intended pur-
pose and actually give the expected results;
- Validation is the risk based, systematic, GMP compliant and documented action
of proving that a defined process actually leads reproducibly to the required re-
sults.
Qualification is an essential prerequisite for process validation: the final proof that
the process is capable of manufacturing the product or products reliably and repro-
ducibly with the specified quality. After successful process validation, the process is
ready and fit for manufacturing products for the market place.
The relationship between the qualification sequence and subsequent process valida-
tion is shown in Fig. 6.07. An important element merits introduction at this point in
time: change control, i.e. the systematic compilation of all changes having been
made to premises, supporting utilities and process equipment since freezing the de-
sign, and also of changes in manufacturing procedures and operational conditions
during later stages of the production system's life cycle (Fig. 6.08). In a first step,
such changes have to be assessed from the risk perspective: if they can be per-
ceived as potentially affecting the capability of the process to manufacture the prod-
ucts reliably and reproducibly in the specified quality, they will have to be submitted
to a full qualification cycle. Only by feeding back these changes into the qualification
sequence – thus keeping qualification up-to-date – the validation status of a produc-
tion system and its supporting utilities can be maintained uninterruptedly during its
entire life cycle.
GMP practices and, in this context, qualification and validation procedures, have as-
sumed quite a bad reputation over the years. GMP is frequently translated - not
completely without justification - into: "Give more paper". Driven by the pharmaceu-
tical inspection authorities, a most unhealthy trend developed over the years: to
qualify and validate what is capable of being qualified or validated – irrespective of
relevance from the product safety point of view. Thus, validation turned into an end
in itself, leading to enormous files of documents with an almost negligible information
density (Hiob [6.02]).
Fortunately the pharmaceutical regulatory authorities have reversed this trend re-
cently: FDA now promotes a risk based approach to inspections (Madsen [6.03]).
So do the Europeans: Annex 15 to the GMP guideline of the European Union and
PIC/S [6.04-6.05] determines that qualification and validation activities should be
based upon risk assessment and limit itself to those parameters which have been
identified as relevant process risks from the GMP point of view [6.02]. This new
approach has since been developed, as explained in Chapter 3.4, into a comprehen-
57
Viewed from the risk management angle, the objective of qualification and validation
is to prove domination of the critical aspects of a given production process and the
equipment and the utilities supporting it. The earlier practice of compiling an ever
increasing data quantity and infinite numbers of files is thus being reoriented into a
trend towards data relevance and file quality – quality thus substitutes quantity.
In parallel to qualification, and co-ordinated with it, technical acceptance tests for
all other functional aspects of the cleanroom system have to be performed according
to the established procedures of Good Engineering Practice, and documented
separately.
Regulatory authorities tend to focus upon the qualification stages subsequent to the
design phases of an investment object. This is understandable from the regulatory
authorities’ point of view and their focus upon process and product. The investor,
however, should perceive qualification also, and above all, as a potent tool for assur-
ing the technical quality and the economic potential of the investment to which he has
committed his money.
The fundament for a successful investment is laid during the design stage [6.06-
6.07], developed usually in three stages as shown in Chapter 4.1.
Unpleasant surprises at the IQ, OQ and PQ stages and during process validation
are, as a rule, the result of sloppiness and omissions during the design phase. The
objective of design qualification (Fig. 6.09) must therefore be to detect all design
weaknesses and omissions as early as possible during the design stage and well
before construction. Corrections are then - in these days of computer-aided design -
straightforward and inexpensive. Errors discovered during and after realisation, on
the other hand, are costly to correct, and frequently it is very difficult at that stage to
correct them satisfactorily.
A potent procedure for discovering design weaknesses, calculation errors and omis-
sions as early as possible during project development is to split Design Qualification
DQ into a sequence of three design qualification steps, each of which is performed at
the end of each project stage and comprehensively documented.
Following this approach, each design stage will end with a qualification exercise.
After its successful completion, the design is ready to proceed into the next develop-
ment stage. The objective of each of these qualification steps is (Fig. 6.10):
58
- Design Qualification 1 (DQ 1): to assess the conceptual design for maturity to
be submitted to the go-ahead decision and subsequently to proceed into basic
design;
- Design Qualification 2 (DQ 2): to assess the maturity of the basic design as
prerequisite for the invitations for tendering to be emitted;
- Design Qualification 3 (DQ 3): to approve detail design, i.e. execution draw-
ings, material lists and material specifications as point of departure for the pur-
chasing decisions regarding the hardware for the building and installation phase.
This preventive approach, which is also recommended in the German guideline VDI
2083 Part 4.1 [6.08], will, in the end, save both time and money; also, full identifica-
tion of management with the project is assured at all times.
The definitions for the three design qualification stages are given in Fig. 6.11, and
Fig. 6.12 shows the relationship between them and the subsequent IQ, OQ and PQ
steps (from Erens [6.09]).
DQ 3 is, however, not yet the absolute end to design activities. Subsequent to DQ 3,
changes will still occur, possibly already during the installation phase if something
has been omitted, or if some requirements have changed. Such changes may also
happen later on during start-up, qualification and validation, in fact, during the entire
life cycle of the facility. As already stated in Chapter 6.2, the objective of change
control is to ensure maintenance of the qualification status forever.
The recommended kick-off date for the change control procedure to be activated is
the successful conclusion of the DQ 3 exercise, as by then changes should be the
exception rather than the rule.
Validation Master Plans identify all qualification and validation activities to be per-
formed during design and realization of an investment object. It is good practice to
elaborate, as a sub-module of this plan, a specific Qualification Master Plan for the
contamination control system as the basic guideline for identifying all qualification
activities devoted to it. Determination of the measurement parameters to be incorpo-
rated into the qualification programme as opposed to the parameters that can be
handled through technical assessment procedures, is one of the most important fea-
tures of this plan. In compliance with Annex 15 - devoted to qualification and valida-
tion issues - of the GMP guideline of the European Community and PIC/S [6.04-
6.05], it is recommended to structure it as follows (Figs. 6.13-6.15):
- objective of the investment object and demarcation of its limits;
59
If some of these topics had already been addressed in the Validation Master Plan,
they should be deleted from the compilation above and substituted by a reference to
said plan.
Based upon the Qualification Master Plan, detailed Qualification Plans are devel-
oped. They are established individually for each qualification stage; separate plans
are assembled for the building shell and for each of its infrastructure systems such as
the HVAC system.
The Qualification Report, again one each per qualification stage and separately for
the building shell and each individual infrastructure system, will list the results of all
checks and tests specified in the corresponding Qualification Plan, going into as
much detail as necessary, and finally summing up the results into a simple state-
ment: passed/not passed. Checks and tests requiring to be repeated should be
condensed into a list of pending actions. Only when all items listed therein have
60
Such Qualification Plans and the corresponding Qualification Reports are normally
structured identically, for instance as follows (Fig. 6.16):
- objective of the facility, its cleanroom system and the remaining utilities;
- short description of the system to be qualified;
- applicable regulatory guidance, normative and company-internal directives and
procedures;
- terms and abbreviations;
- signature lists, covering all people involved in the qualification activities covered
by this specific qualification plan and report;
- a detailed compilation of the required checks and tests, together with (where ap-
plicable) the measurement forms complete with acceptance criteria;
- calibration certificates (where applicable) of the measurement instrumentation;
- formal requirements for drawings and functional diagrams;
- allocation of responsibilities.
For realizing all checks and tests comprehensively, without missing anything, the
elaboration of a complete set of qualification checklists is very helpful. Extracts
from such checklists for DQ 2 and IQ are shown in Figs. 6.17-6.18. Comprehensive
sets of checklists for all qualification stages regarding the building and its HVAC sys-
tem are to be found in Appendix A3. The lists compiled there may be too detailed
for a small investment object, but not detailed enough for a complex case. Thus,
they should be adapted individually to the requirements of each individual investment
object.
Parameters for which technical acceptance tests are sufficient are not addressed in
these checklists.
The ISO families of cleanroom technology standards provide a sound and compre-
hensive fundament for the qualification of cleanroom systems:
- ISO 14644-4 [6.10] devotes its Annex C to a very comprehensive compilation of
the requirements for the approval and qualification of cleanrooms. Fig. 6.19 pre-
sents the sequence of development, approval and qualification stages of an in-
vestment project and correlates them with the occupancy states of the clean
area. Annex C also contains a compilation of the many checks, tests and verifi-
cations to be performed during the different approval and qualification stages of a
facility.
61
- ISO 14644-3 [6.11] offers detailed guidance for the measurement of physical pa-
rameters for qualification and acceptance tests as well as for process monitoring.
It addresses all such measurement tasks referred to in Parts 1 to 8 of the ISO
14644 series - a total of 13 tasks (Figs. 6.20-6.21). In addition, the minimum per-
formance requirements for the test instruments are specified in detail; an exam-
ple is given in Fig. 6.22.
- ISO 14698-1 [6.12] provides comprehensive guidance regarding microbiological
measurement procedures and ISO 14698-2 [6.13] regarding the assessment and
interpretation of biocontamination data.
Some words regarding the regulatory authorities [6.14-6.15]: the inspectors ap-
pointed by them are public servants committed to ensuring that patients are supplied
with safe and effective medicinal products. If anything goes wrong, they will have to
bear their share of responsibility. Therefore, they are obliged to be critical, and to
inspect with a worst-case attitude based upon risk assessments. This critical attitude
should be viewed positively by industry: a lot can be learned from the inspectors'
comments and transformed into process improvements.
An idea regarding the aspects on which inspectors might focus when auditing phar-
maceutical infrastructure systems such as the HVAC system can be gleaned from
the PIC/S aide-mémoire on the inspection of utilities [6.16] which not only identifies
the key topics, but also crucial questions regarding them.
6.9 References
[6.01] PIC/S PE 010-3: PIC/S guide to good practices for preparation of medicinal
products in healthcare establishments. Pharmaceutical Inspection Co-oper-
ation Scheme PIC/S, Pharmaceutical Inspection Convention PIC, Geneva
(1 October 2008).
[6.02] Hiob M.: Qualifizierung und Validierung nach Annex 15 des EG-GMP-Leit-
fadens - Teil 1: Allgemeine Anmerkungen aus Inspektorensicht (Qualification
and validation according to Annex 15 of the GMP guideline of the European
Union - Part 1: General remarks from an inspector's perspective). Pharm.
Ind. 63 (2001) 6, 563-570.
[6.03] Madsen R.E.: The quality systems approach to real compliance. Renhets-
teknik (Clean Technology) 36 (2007) 3, 10-15..
[6.04] Eudralex, the rules governing medicinal products in the European Union - Vol.
4: EU guidelines to Good Manufacturing Practice for medicinal products for
human and veterinary use. European Commission, Brussels (frequently up-
dated).
[6.05] PIC/S PE 009-9: Guide to Good Manufacturing Practice for medicinal prod-
ucts (divided into four parts: Introduction, Part I, Part II, Annexes). Pharma-
ceutical Inspection Convention PIC, Pharmaceutical Inspection Co-operation
Scheme PIC/S, Geneva (1 September 2009).
[6.06] MacDonald A.: Do you DQ? Design qualification challenges and considera-
tions. Pharmaceutical Engineering 25 (2005) 2, 30-38.
[6.07] Chvaicer Y.: Design qualification in practice - from strategy to report. Phar-
maceutical Engineering 25 (2005) 4, 92-104.
[6.08] VDI 2083: Cleanroom technology - Part 4.1: Planning, construction and
start-up of cleanrooms. Beuth Verlag, Berlin (October 2006).
[6.15] Fetsch J., Mocha Denise: Vorbereitung und Begleitung von FDA-Inspektio-
nen (Preparation and accompaniment of FDA inspections). Pharm. Ind. 67
(2005) 4, 455-461.